Table 1. Patient characteristics.
Patient No. | T stage | N stage | No. nodes | Max node size (centimeters) | Chemo | Primary tumor site | HPV status | Disease status |
---|---|---|---|---|---|---|---|---|
1 | 2 | 2c | 5 | 3 | q 3 weeks CDDP | tongue base | positive | no recurrence |
2 | 2 | 2b | 4 | 3.8 | q 3 weeks CDDP | tonsil | positive | no recurrence |
3 | 2 | 2c | 5 | 4.9 | q 3 weeks CDDP | tongue base | positive | no recurrence |
4 | 4a | 1 | 1 | 2.3 | q 3 weeks CDDP | tongue base | positive | no recurrence |
5 | 2 | 2a | 1 | 3 | q 3 weeks CDDP | tonsil | positive | no recurrence |
6 | 2 | 2b | 2 | 2.9 | q 3 weeks CDDP | tonsil | positive | no recurrence |
7 | 1 | 2b | 2 | 2.6 | q 3 weeks CDDP | tongue base | positive | no recurrence |
8 | x | 2b | 2 | 3.6 | q 3 weeks CDDP | unknown | negative | no recurrence |
9 | 1 | 2b | 2 | 3.8 | Weekly CDDP | tongue base | positive | no recurrence |
10 | x | 2b | 2 | 1.9 | Weekly CDDP | unknown | negative | no recurrence |
11 | 4a | 2b | 3 | 6 | Weekly CDDP | tonsil | positive | no recurrence |
12 | 1 | 2b | 2 | 2.4 | Weekly CDDP | tonsil | positive | no recurrence |
13 | 2 | 3 | 7 | 8 | Weekly CDDP | base tongue | positive | no recurrence |
14 | 1 | 2b | 3 | 2.2 | weekly cetuximab | tongue base | negative | Persistent disease in right neck, salvaged with surgery. Second local recurrence in right neck, treated with SBRT. Third recurrence, on anti-PD1 therapy with partial response |
15 | x | 3 | 6 | 6.5 | weekly cetuximab | unknown | Positive | rapid recurrence, passed away |
Abbreviations: HPV, human papilloma virus; CDDP, cisplatin; SBRT, stereotactic body radiation therapy.